- Home
- SNOA vs CYCN Comparison
SNOA vs CYCN Comparison
Compare SNOA & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- CYCN
- Stock Information
- Founded
- SNOA 1999
- CYCN 2018
- Country
- SNOA United States
- CYCN United States
- Employees
- SNOA N/A
- CYCN N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- SNOA Health Care
- CYCN Health Care
- Exchange
- SNOA Nasdaq
- CYCN Nasdaq
- Market Cap
- SNOA 6.4M
- CYCN 6.5M
- IPO Year
- SNOA 2007
- CYCN N/A
- Fundamental
- Price
- SNOA $2.90
- CYCN $2.80
- Analyst Decision
- SNOA
- CYCN
- Analyst Count
- SNOA 0
- CYCN 0
- Target Price
- SNOA N/A
- CYCN N/A
- AVG Volume (30 Days)
- SNOA 25.5K
- CYCN 21.8K
- Earning Date
- SNOA 06-17-2025
- CYCN 08-06-2025
- Dividend Yield
- SNOA N/A
- CYCN N/A
- EPS Growth
- SNOA N/A
- CYCN N/A
- EPS
- SNOA N/A
- CYCN N/A
- Revenue
- SNOA $14,288,000.00
- CYCN $2,081,000.00
- Revenue This Year
- SNOA $38.54
- CYCN N/A
- Revenue Next Year
- SNOA N/A
- CYCN N/A
- P/E Ratio
- SNOA N/A
- CYCN N/A
- Revenue Growth
- SNOA 12.20
- CYCN N/A
- 52 Week Low
- SNOA $1.75
- CYCN $1.27
- 52 Week High
- SNOA $9.37
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- SNOA 38.85
- CYCN 41.24
- Support Level
- SNOA $2.81
- CYCN $3.02
- Resistance Level
- SNOA $3.45
- CYCN $3.16
- Average True Range (ATR)
- SNOA 0.13
- CYCN 0.21
- MACD
- SNOA -0.05
- CYCN -0.03
- Stochastic Oscillator
- SNOA 10.77
- CYCN 16.26
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.